Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:960615.
doi: 10.1155/2015/960615. Epub 2015 Mar 2.

Autoimmune polyendocrine syndrome 3 onset with severe ketoacidosis in a 74-year-old woman

Affiliations

Autoimmune polyendocrine syndrome 3 onset with severe ketoacidosis in a 74-year-old woman

Stefano Benedini et al. Case Rep Endocrinol. 2015.

Abstract

Type 1 diabetes mellitus (T1D), autoimmune thyroid disease, and autoimmune gastritis often occur together forming the so-called autoimmune polyendocrine syndrome type 3 (APS3). We here report a clinical case of a 74-year-old woman who presented for the first time with severe hyperglycemia and ketoacidosis diagnosed as T1D. Further clinical investigations revealed concomitant severe hypothyroidism with autoimmune thyroid disease and severe cobalamin deficiency due to chronic atrophic gastritis. The diagnosis of type 1 diabetes mellitus was confirmed by the detection of autoantibodies against glutamic acid decarboxylase 65, islet cell antibodies, and anti-insulin autoantibodies. Anti-thyroperoxidase, anti-thyroglobulin, and anti-gastric parietal cell antibodies were also clearly positive. The case emphasized that new onset diabetic ketoacidosis, hypothyroidism, and cobalamin deficiency may simultaneously occur, and one disease can mask the features of the other, thereby making diagnosis difficult. It is noteworthy that an APS3 acute episode occurred in an asymptomatic elder woman for any autoimmune diseases.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS) Acta Biomedica de l'Ateneo Parmense. 2003;74(1):9–33. - PubMed
    1. Atkinson M. A., Eisenbarth G. S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet. 2001;358(9277):221–229. doi: 10.1016/s0140-6736(01)05415-0. - DOI - PubMed
    1. Betterle C., Lazzarotto F., Fusari A., et al. Pancreatic autoantibodies in Italian patients with newly diagnosed type 1 diabetes mellitus over the age of 20 years. Acta Diabetologica. 2006;43(3):79–83. doi: 10.1007/s00592-006-0217-3. - DOI - PubMed
    1. Riley W. J., Maclaren N. K., Lezotte D. C., Spillar R. P., Rosenbloom A. L. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. The Journal of Pediatrics. 1981;99(3):350–354. doi: 10.1016/s0022-3476(81)80316-2. - DOI - PubMed
    1. Mouradian M., Abourizk N. Diabetes mellitus and thyroid disease. Diabetes Care. 1983;6(5):512–520. doi: 10.2337/diacare.6.5.512. - DOI - PubMed